Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes [Phase 1]
Phase 1 trial of lenalidomide in pediatric patients with relapsed or refractory myelodysplastic syndromes and solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
The clinical trial evaluating blood stem cell transplants in adults and children with various hematologic cancers, sponsored by Columbia Uni…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 update on non-myeloablative allogeneic stem cell transplantation using mis-matched family donor cells purged with Campath (alemtuzum…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating the efficacy of T cell-depleted allogeneic non-myeloablative stem cell transplantation; the study in Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath [Phase 2]
Phase 2 study of an allogeneic non-myeloablative stem cell transplant using matched family member donor cells purged with Campath (alemtuzum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [Phase 2]
A Phase 2 trial evaluating a conditioning regimen of total-body irradiation with tacrolimus and mycophenolate mofetil followed by bone marro…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial evaluating donor bone marrow transplantation for hematologic cancers has completed; the study enrolled patients with leukemia,…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) [Phase 2]
A Phase 2 trial of azacitidine followed by GM-CSF in patients with myelodysplastic syndromes and leukemia was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Survey on QUality of Life In myeloDisplasia (SQUID)
This entry reports the completion of a Janssen-sponsored clinical trial (SQUID) assessing quality of life in patients with myelodysplastic s…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [Phase 2]
A Phase 2 clinical trial evaluated the use of sargramostim after bone marrow transplantation in patients with myelodysplastic syndromes; the…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]
Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cance…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating T-cell depleted allogeneic stem cell transplantation for hematologic malignancies; study is completed with…
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia [Phase 1, Phase 2]
Phase 1/2 trial of vorinostat plus low-dose cytarabine for high-risk myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS withdrawal · 2014-03-20Clinical Trial Update: Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
A Phase 1/2 trial investigating azacitidine with or without Ceplene (histamine dihydrochloride) and interleukin-2 for higher-risk myelodyspl…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA) [Phase 2]
Phase 2 trial evaluating azacitidine combined with epoetin beta in IPSS low-risk and intermediate-1 myelodysplastic syndrome patients resist…
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy plus biological therapy followed by peripheral stem cell transplantation for hematologic ca…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases [Phase 3]
Phase 3 trial comparing sibling donor peripheral blood stem cell transplant versus sibling donor bone marrow transplant in hematologic disea…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer [Phase 2]
Phase 2 trial evaluating cyproheptadine hydrochloride with nutritional supplementation in weight-loss associated cancer in young patients wa…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies [Phase 1, Phase 2]
The document reports the completion and results posting of a Phase 1/2 study evaluating a conditioning regimen of clofarabine, melphalan, an…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial in pediatric patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes evaluated a monoclonal…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes [Phase 2]
This ClinicalTrials.gov entry reports a completed Phase 2 study evaluating amifostine in pediatric patients with newly diagnosed de novo mye…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Proteases in Patients With Prostate Cancer That Has Spread to the Bone
This document reports the completion status of a clinical trial investigating proteases in patients with prostate cancer that has spread to …
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Sorafenib in Myelodysplastic Syndrome [Phase 2]
A Phase 2 trial of sorafenib in myelodysplastic syndromes and chronic myelomonocytic leukemia was terminated, with results posted in 2014.
-
CLINICAL_TRIALS withdrawal · 2014-02-11Clinical Trial Update: AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS [Phase 1, Phase 2]
A Phase 1/2 trial evaluating AMD3100 with busulfan, fludarabine, and thymoglobulin for allogeneic stem cell transplantation in acute myeloid…
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: Clofarabine in Adult Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for clofarabine in adult patients with advanced solid tumors and various hematologic conditions; the…